BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schein YL, Madebo T, Andersen HE, Arnesen TM, Dyrhol-Riise AM, Tveiten H, White RA, Winje BA. Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study. BMC Infect Dis 2018;18:587. [PMID: 30453946 DOI: 10.1186/s12879-018-3468-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Winje BA, Grøneng GM, White RA, Akre P, Aavitsland P, Heldal E. Immigrant screening for latent tuberculosis infection: numbers needed to test and treat, a Norwegian population-based cohort study. BMJ Open 2019;9:e023412. [PMID: 30782706 DOI: 10.1136/bmjopen-2018-023412] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Ahmad BB, Kristensen KL, Glenthoej JP, Poulsen A, Bryld AG, Huber FG, Andersen EM, Ravn P. Latent tuberculosis infection among minor asylum seekers in Denmark. Eur Respir J 2020;55:1901688. [PMID: 31558661 DOI: 10.1183/13993003.01688-2019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Park SY, Lee E, Lee EJ, Kim TH, Kim YK. Screening and Treatment of Latent Tuberculosis Infection among Healthcare Workers at a Referral Hospital in Korea. Infect Chemother 2019;51:355-64. [PMID: 31898423 DOI: 10.3947/ic.2019.51.4.355] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
4 Surey J, Stagg HR, Yates TA, Lipman M, White PJ, Charlett A, Muñoz L, Gosce L, Rangaka MX, Francis M, Hack V, Kunst H, Abubakar I. An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study. BMC Infect Dis 2021;21:90. [PMID: 33478428 DOI: 10.1186/s12879-021-05766-9] [Reference Citation Analysis]
5 Chacón A, Alarcón E, López L. [Factors associated with completion of isoniazid preventive therapy in children in Quito, Ecuador (2014-2016 and 2018)Fatores associados à adesão à terapia preventiva com isoniazida em crianças de Quito, Equador (2014-2016 e 2018)]. Rev Panam Salud Publica 2019;43:e97. [PMID: 31892926 DOI: 10.26633/RPSP.2019.97] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Rustage K, Lobe J, Hayward SE, Kristensen KL, Margineanu I, Stienstra Y, Goletti D, Zenner D, Noori T, Pareek M, Greenaway C, Friedland JS, Nellums LB, Hargreaves S; ESGITM and ESGMYC study groups. Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis. Lancet Infect Dis 2021:S1473-3099(21)00052-9. [PMID: 34363771 DOI: 10.1016/S1473-3099(21)00052-9] [Reference Citation Analysis]
7 Alvarez GG, Van Dyk D, Mallick R, Lesperance S, Demaio P, Finn S, Potvin SE, Patterson M, Pease C, Amaratunga K, Hui C, Cameron DW, Mulpuru S, Aaron SD, Momoli F, Zwerling A. The implementation of rifapentine and isoniazid (3HP) in two remote Arctic communities with a predominantly Inuit population, the Taima TB 3HP study. Int J Circumpolar Health 2020;79:1758501. [PMID: 32379538 DOI: 10.1080/22423982.2020.1758501] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Lin SY, Chien JY, Chiang HT, Lu MC, Ko WC, Chen YH, Hsueh PR. Ambulatory independence is associated with higher incidence of latent tuberculosis infection in long-term care facilities in Taiwan. J Microbiol Immunol Infect 2021;54:319-26. [PMID: 31624017 DOI: 10.1016/j.jmii.2019.07.008] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Alvarez GG, Sullivan K, Pease C, Van Dyk D, Mallick R, Taljaard M, Grimshaw JM, Amaratunga K, Allen C, Brethour K, Mulpuru S, Pakhale S, Aaron SD, Cameron DW, Alsdurf H, Hui C, Zwerling AA. Effect of implementation of a 12 dose once-weekly treatment (3HP) in addition to standard regimens to prevent TB on completion rates: Interrupted time series design. Int J Infect Dis 2022:S1201-9712(22)00072-8. [PMID: 35121126 DOI: 10.1016/j.ijid.2022.01.063] [Reference Citation Analysis]
10 Spruijt I, Tesfay Haile D, Suurmond J, van den Hof S, Koenders M, Kouw P, van Noort N, Toumanian S, Cobelens F, Goosen S, Erkens C. Latent tuberculosis screening and treatment among asylum seekers: a mixed-methods study. Eur Respir J 2019;54:1900861. [DOI: 10.1183/13993003.00861-2019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]